Jaguar Health's CDMO Improves Manufacturing Processes to Support the Expanded Crofelemer Manufacturing Volume Expected to be Required for Potential Expanded Indications, Including a Potential Indication for Cancer Therapy-related Diarrhea
Stock Information for Jaguar Health Inc.
Loading
Please wait while we load your information from QuoteMedia.